Anderson CJ - Search Results

1

Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.

Bass LA, Lanahan MV, Duncan JR, Erion JL, Srinivasan A, Schmidt MA, Anderson CJ. Bass LA, et al. Among authors: anderson cj. Bioconjug Chem. 1998 Mar-Apr;9(2):192-200. doi: 10.1021/bc970158h. Bioconjug Chem. 1998. PMID: 9548534

2

Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.

Rogers BE, Franano FN, Duncan JR, Edwards WB, Anderson CJ, Connett JM, Welch MJ. Rogers BE, et al. Among authors: anderson cj. Cancer Res. 1995 Dec 1;55(23 Suppl):5714s-5720s. Cancer Res. 1995. PMID: 7493333

3

Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs.

Edwards WB, Fields CG, Anderson CJ, Pajeau TS, Welch MJ, Fields GB. Edwards WB, et al. Among authors: anderson cj. J Med Chem. 1994 Oct 28;37(22):3749-57. doi: 10.1021/jm00048a011. J Med Chem. 1994. PMID: 7966134

4

In vitro and in vivo evaluation of copper-64-octreotide conjugates.

Anderson CJ, Pajeau TS, Edwards WB, Sherman EL, Rogers BE, Welch MJ. Anderson CJ, et al. J Nucl Med. 1995 Dec;36(12):2315-25. J Nucl Med. 1995. PMID: 8523125 Free article.

5

Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.

Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ. Rogers BE, et al. Among authors: anderson cj. Bioconjug Chem. 1996 Jul-Aug;7(4):511-22. doi: 10.1021/bc9600372. Bioconjug Chem. 1996. PMID: 8853465

6

Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.

Duncan JR, Stephenson MT, Wu HP, Anderson CJ. Duncan JR, et al. Among authors: anderson cj. Cancer Res. 1997 Feb 15;57(4):659-71. Cancer Res. 1997. PMID: 9044843

7

Efficient production of high specific activity 64Cu using a biomedical cyclotron.

McCarthy DW, Shefer RE, Klinkowstein RE, Bass LA, Margeneau WH, Cutler CS, Anderson CJ, Welch MJ. McCarthy DW, et al. Among authors: anderson cj. Nucl Med Biol. 1997 Jan;24(1):35-43. doi: 10.1016/s0969-8051(96)00157-6. Nucl Med Biol. 1997. PMID: 9080473

8

Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.

Anderson CJ, Jones LA, Bass LA, Sherman EL, McCarthy DW, Cutler PD, Lanahan MV, Cristel ME, Lewis JS, Schwarz SW. Anderson CJ, et al. J Nucl Med. 1998 Nov;39(11):1944-51. J Nucl Med. 1998. PMID: 9829587 Free article.

9

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Lewis JS, et al. Among authors: anderson cj. J Med Chem. 1999 Apr 22;42(8):1341-7. doi: 10.1021/jm980602h. J Med Chem. 1999. PMID: 10212119

10

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Among authors: anderson cj. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters